In 2019, the global probiotics market was valued at USD 48.88 billion and is projected to reach USD 94.48 billion by 2027, registering a CAGR of 7.9% over the forecast period. North America accounted for 16.98% of the global share in 2019. Within the U.S., the sector is expected to expand significantly, with estimates suggesting it could generate around USD 17.99 billion by 2032. This growth will be fueled by increasing demand for probiotic-enriched and immunity-supporting foods, reflecting their well-established health benefits.
Growing awareness of preventive healthcare, along with consumer preference for safe, natural, and health-enhancing products, is expected to drive market growth. Efforts from professional bodies and associations are also supporting adoption. For example, the Nutrition Society of Malaysia (NSM) initiated the Probiotics Education Program (PEP) to educate consumers about the role of probiotics in promoting better health.
Information Source: https://www.fortunebusinessinsights.com/industry-reports/probiotics-market-100083
Rising Demand for Immunity-Boosting Products During COVID-19
Although the COVID-19 pandemic disrupted supply chains and the global economy in the short term, it also accelerated demand for immune-supportive and functional products. Probiotics, known for their digestive and immunity-enhancing properties, saw a surge in interest during this period, a trend that is expected to persist. For instance, in April 2020, Probi—a leading global probiotics company—reported a sharp increase in demand as consumers sought products that could strengthen immunity.
Report Scope
This report provides an in-depth assessment of the probiotics market, covering growth drivers, challenges, opportunities, and restraints. It also analyzes regional dynamics, industry trends, and strategies adopted by major players. Key activities such as product launches, mergers, acquisitions, and partnerships between 2020 and 2027 are also highlighted.
Key Growth Drivers
According to the World Health Organization (WHO), global obesity rates have nearly tripled since 1975, with related chronic diseases such as diabetes becoming more common. This shift is pushing consumers toward healthier diets and functional foods, including probiotics for digestive health and immunity. Moreover, technological advancements are enabling companies to raise awareness and educate consumers, further accelerating the adoption of probiotic products.
Market Segmentation Highlights
In 2019, supermarkets and hypermarkets dominated the sales channel, contributing 61.33% of total probiotic sales. Their wide product range, frequent promotions, and easy accessibility make them the most popular distribution platform.
Regional Insights
Asia-Pacific remains the dominant region in the probiotics industry, supported by a strong tradition of consuming fermented foods and beverages that naturally benefit gut health. North America, valued at USD 8.30 billion in 2019, is expected to see strong growth between 2020 and 2027 due to the rising prevalence of chronic illnesses and increased investment in innovative probiotic solutions.
Competitive Landscape
Leading players are focusing on product development, research and innovation, and strategic partnerships to enhance global presence and strengthen their distribution networks. Collaborations, acquisitions, and new product launches remain key growth strategies.
Prominent Companies in the Market:
- Danone S.A. (France)
- Lallemand Inc. (Canada)
- Yakult Honsha Co., Ltd. (Japan)
- Nestlé S.A. (Switzerland)
- DuPont (Danisco A/S) (USA)
- Chr. Hansen (Denmark)
- Kerry Inc. (Ireland)
- Post Holdings, Inc. (USA)
- PepsiCo, Inc. (USA)
- Evolve Biosystems, Inc. (USA)
Recent Development
- June 2020: Pendulum Therapeutics launched Pendulum Glucose Control, a clinically tested medical probiotic formulated to lower post-meal blood sugar and A1C levels. This marked a significant innovation in probiotics for managing metabolic health.
